Top

Archives of Osteoporosis

Published in:

01-12-2020 | Review

Variation of urinary and serum bone turnover marker reference values among pre and postmenopausal women in Asia: a systematic review

Authors: Hasanga Rathnayake, Sarath Lekamwasam, Chandima Wickramatilake, Janaka Lenora

Published in: Archives of Osteoporosis | Issue 1/2020

Abstract

Purpose

Bone turnover markers (BTMs) are not widely used in clinical decision-making partly due to the wide variation of the reference values. This paper describes the geographical variation in BTMs reported from Asian countries.

Method

A systematic search was conducted using the PubMed, EMBASE, and Ovid. We searched for BTMs or individual BTMs in Asia or different countries in the Asian region. Original research which published BTM values were included while reviews, comments, and meta-analyses were excluded.

Results

Of 650 articles, 23 fulfilled the selection criteria and were considered for this study. Among premenopausal women, mean intact OC ranged from 3.35 in Japan to 7.38 ng/mL (55%) in Thailand while it ranged between 3.35 and 5.8 ng/mL (42%) within Japan. Mean BALP varied from 15.9 in India to 41.2 U/L (61%) in Japan whereas in India, it ranged between 15.9 and 53.7 U/L (70%). Mean sP1NP ranged from 29.5 in Japan to 38.02 ng/mL in China (22%) whereas sCTX varied from 0.26 in Thailand to 0.099 ng/mL (62%) in Japan. Among postmenopausal women, mean total OC ranged from 10.02 in India to 29.8 ng/mL (66%) in Japan and intact OC ranged between 2.69 and 9.49 ng/mL (72%) within China. Mean BALP ranged from 20.9 in Japan to 60.28 U/L (65%) in China, and within China, it ranged from 28.2 to 60.28 U/L (53%). Mean sP1NP ranged from 40.11 in China to 56.4 ng/mL (29%) in Japan whereas it ranged within China from 40.11 to 53.76 ng/mL (25%). Mean sCTX varied from 0.25 to 0.433 ng/mL (42%) between the same countries respectively while within China, it varied from 0.25 to 0.395 ng/mL (37%). Urinary BTMs showed a lesser variation.

Conclusion

A wide inter-country and intra-country variation of serum BTMs was observed among pre and postmenopausal women in Asia. Differences in selection criteria of subjects and those inherited to analytical methods may have contributed to these differences.

Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288PubMedPubMedCentral

Ahlborg HG, Rosengren BE, Jarvinen TL, Rogmark C, Nilsson JA, Sernbo I, Karlsson MK (2010) Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years. BMC Musculoskelet Disord 11:48PubMedPubMedCentral

Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, Watts NB (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25:1439–1443PubMedPubMedCentral

Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26:97–122PubMedPubMedCentral

Lenora J, Ivaska KK, Gerdhem P (2009) Use of bone turnover markers in osteoporosis. Clinic Rev Bone Miner Metab 8:1–14

Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS (2008) The cell biology of bone metabolism. J Clin Pathol 61:577–587PubMed

Meng J, Zhang D, Pan N, Sun N, Wang Q, Fan J, Zhou P, Zhu W, Jiang L (2015) Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis. PeerJ 3:e971PubMedPubMedCentral

Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, Myers G, Silverman S, Vesper HW, Lee D, Payette M, Randall S (2012) National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int 23:2425–2433PubMedPubMedCentral

Lenora J, Akesson K, Gerdhem P (2010) Effect of precision on longitudinal follow-up of bone mineral density measurements in elderly women and men. J Clin Densitom 13:407–412PubMed

10.

Čepelak I, Čvorišćec D (2009) Biochemical markers of bone remodeling–review. Biochemia Med 19:17–35

11.

Diaz de Barboza G, Guizzardi S, Tolosa de Talamoni N (2015) Molecular aspects of intestinal calcium absorption. World J Gastroenterol 21:7142–7154PubMedPubMedCentral

12.

Hu WW, Zhang Z, He JW, Fu WZ, Wang C, Zhang H, Yue H, Gu JM, Zhang ZL (2013) Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women. Int J Endocrinol 2013:513925PubMedPubMedCentral

13.

Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L (2014) Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender. PLoS One 9:e103841PubMedPubMedCentral

14.

Lee J, Vasikaran S (2012) Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med 32:105–112PubMedPubMedCentral

15.

Vasikaran SD, Chubb SP, Ebeling PR, Jenkins N, Jones GR, Kotowicz MA, Morris HA, Schneider HG, Seibel MJ, Ward G (2014) Harmonised Australian reference intervals for serum PINP and CTX in adults. Clin Biochem Rev 35:237–242PubMedPubMedCentral

16.

Ma L, Song Y, Li C, Wang E, Zheng D, Qu F, Zhou J (2016) Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected]. Climacteric 19:400–405PubMed

17.

Wei QS, Huang L, Tan X, Chen ZQ, Chen SM, Deng WM (2016) Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women. Scand J Clin Lab Invest 76:33–39PubMed

18.

Wu XY, Zhang H, Xie H, Luo XH, Peng YQ, Yuan LQ, Dai RC, Sheng ZF, Wu XP, Liao EY (2014) Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China. Osteoporos Int 25:943–952PubMed

19.

Zhou XW, Wu XY, Luo L, Guo LJ, Lei MX, Zhang H, Xie H, Peng YQ, Wu XP, Liao EY (2011) The relationship between bone turnover markers and BMD decreasing rates in Chinese middle-aged women. Clin Chim Acta 412:1648–1657PubMed

20.

Xu XJ, Shen L, Yang YP, Zhu R, Shuai B, Li CG, Wu MX (2013) Serum beta-catenin levels associated with the ratio of RANKL/OPG in patients with postmenopausal osteoporosis. Int J Endocrinol 2013:534352PubMedPubMedCentral

21.

Zhang Y, Feng E, Xu Y, Wang W, Zhang T, Xiao L, Chen R, Lin Y, Chen D, Lin L, Chen K, Lin Y (2015) Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Int J Clin Exp Med 8:16352–16357PubMedPubMedCentral

22.

Tian L, Yang R, Wei L, Liu J, Yang Y, Shao F, Ma W, Li T, Wang Y, Guo T (2017) Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: a cross-sectional study in Gansu province, Northwestern of China. Medicine 96:e8294PubMedPubMedCentral

23.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L (2011) The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause (New York, NY) 18:1237–1243

24.

Chen Y, Guo Q, Zhang M, Song S, Quan T, Zhao T, Li H, Guo L, Jiang T, Wang G (2016) Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women. Bone Res 4:16012PubMedPubMedCentral

25.

Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM (2007) Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal 21:55–60PubMedPubMedCentral

26.

Desai Meena P, Khatkhatay MI, Bhanu Prakash KV, Savardekar LS, Shah RS, Ansari Z (2007) Hormonal profiles and biochemical indices of bone turnover in Indian women. Osteoporos Int 18:923–929PubMed

27.

Kumar A, Devi SG, Mittal S, Shukla DK, Sharma S (2013) A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women. Indian J Med Res 137:48–56PubMedPubMedCentral

28.

Nomura Y, Yoshizaki A, Yoshikata H, Kikuchi R, Sakakibara H, Chaki O, Fukunaga M, Hirahara F (2013) Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values. J Bone Miner Metab 31:644–651PubMed

29.

Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2011) Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol 21:608–620PubMed

30.

Orito S, Kuroda T, Onoe Y, Sato Y, Ohta H (2009) Age-related distribution of bone and skeletal parameters in 1,322 Japanese young women. J Bone Miner Metab 27:698–704PubMed

31.

Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2006) Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 17:1086–1095PubMed

32.

Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int 15:981–991PubMed

33.

Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I (2000) The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 15:1537–1544PubMed

34.

Jeong TD, Lee W (2014) Relationship between serum total cholesterol level and serum biochemical bone turnover markers in healthy pre- and postmenopausal women. Biomed Res Int 2014:398397PubMedPubMedCentral

35.

Park SG, Jeong SU (2018) The changes of CTX, DPD, osteocalcin, and bone mineral density during the postmenopausal period. Ann Rehabil Med 42:441–448PubMedPubMedCentral

36.

Naeem ST, Hussain R, Raheem A, Siddiqui I, Ghani F, Khan AH (2016) Bone turnover markers for osteoporosis status assessment at baseline in postmenopausal Pakistani females. J Coll Physicians Surg Pak 26:408–412PubMed

37.

Pongchaiyakul C, Kosulwat V, Charoenkiatkul S, Chailurkit LO, Rojroongwasinkul N, Rajatanavin R (2008) The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women. J Med Assoc Thai 91:295–302PubMed

38.

Iwasaki E, Morakote N, Chaovistsaree S, Matsuo H (2014) Bone mineral density and bone turnover among young women in Chiang Mai, Thailand. Kobe J Med Sci 59:E149–E156PubMed

39.

Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420PubMed

40.

Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM (2013) The clinical utility of bone marker measurements in osteoporosis. J Transl Med 11:201PubMedPubMedCentral

41.

Marshall WJ, Lapsley M, Day A, Ayling RM (2014) Clinical biochemistry: metabolic and clinical aspects. Elsevier Health Sciences, London, pp 604–635

42.

Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover-uses and limitations. Ann Clin Biochem 51:189–202PubMed

43.

Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, Ettinger B (2002) Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87:3051–3056PubMed

44.

Zhang L, Choi HJ, Estrada K, Leo PJ, Li J, Pei YF, Zhang Y, Lin Y, Shen H, Liu YZ, Liu Y, Zhao Y, Zhang JG, Tian Q, Wang YP, Han Y, Ran S, Hai R, Zhu XZ, Wu S, Yan H, Liu X, Yang TL, Guo Y, Zhang F, Guo YF, Chen Y, Chen X, Tan L, Zhang L, Deng FY, Deng H, Rivadeneira F, Duncan EL, Lee JY, Han BG, Cho NH, Nicholson GC, McCloskey E, Eastell R, Prince RL, Eisman JA, Jones G, Reid IR, Sambrook PN, Dennison EM, Danoy P, Yerges-Armstrong LM, Streeten EA, Hu T, Xiang S, Papasian CJ, Brown MA, Shin CS, Uitterlinden AG, Deng HW (2014) Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet 23:1923–1933PubMed

45.

Redmond J, Fulford AJ, Jarjou L, Zhou B, Prentice A, Schoenmakers I (2016) Diurnal rhythms of bone turnover markers in three ethnic groups. J Clin Endocrinol Metab 101:3222–3230PubMedPubMedCentral

46.

Greenblatt MB, Tsai JN, Wein MN (2017) Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem 63:464–474PubMed

47.

Eastell R, Pigott T, Gossiel F, Naylor KE, Walsh JS, Peel NFA (2018) Diagnosis of endocrine disease: bone turnover markers: are they clinically useful? Eur J Endocrinol 178:R19–r31PubMed

48.

Wu CH, Chang YF, Chen CH, Lewiecki EM, Wuster C, Reid I, Tsai KS, Matsumoto T, Mercado-Asis LB, Chan DC, Hwang JS, Cheung CL, Saag K, Lee JK, Tu ST, Xia W, Yu W, Chung YS, Ebeling P, Mithal A, Ferrari SL, Cooper C, Lin GT, Yang RS (2019) Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region. J Clin Densitom (In press). https://www.sciencedirect.com/science/article/pii/S1094695019300368

49.

Iizuka Y, Iizuka H, Kaneko T, Mieda T, Takechi R, Suzuki H, Sorimachi Y, Suto T, Tachibana M, Yoneyama T, Omodaka T, Hashimoto S, Hamano N, Sakane H, Shimoyama D, Kohama I, Ohshima A, Nozaki T, Kamiyama M, Moteki T, Ohshima A, Takamine S, Honda A, Ueno A, Tajika T, Okamura K, Warita T, Yonemoto Y, Shitara H, Ohsawa T, Takagishi K (2016) Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients. Injury 47:2484–2489PubMed

50.

Ahn SH, Park SY (2019) Use of bone turnover markers in clinical practice for the management of osteoporosis in Korea: from the survey on the prescription pattern of bone turnover markers. J Bone Metab 26:271–277PubMedPubMedCentral

51.

Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Black DM, Delmas PD, Eastell R (2009) Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 24:389–397PubMed

52.

Gossiel F, Finigan J, Jacques R, Reid D, Felsenberg D, Roux C, Glueer C, Eastell R (2014) Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state. BoneKEy Rep 3:573PubMedPubMedCentral

53.

Wayne PA (2004) Application of biochemical markers of bone turnover in the assessment and monitoring of bone diseases; approved guideline. CLSI document C48-A. Clinical and Laboratory Standards Institute. https://clsi.org/standards/products/clinical-chemistry-and-toxicology/documents/c48/

Title: Variation of urinary and serum bone turnover marker reference values among pre and postmenopausal women in Asia: a systematic review
Authors: Hasanga Rathnayake
Sarath Lekamwasam
Chandima Wickramatilake
Janaka Lenora
Publication date: 01-12-2020
Publisher: Springer London
Published in: Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-020-00722-7

At a glance: The STEP trials

Springer Medicine

Variation of urinary and serum bone turnover marker reference values among pre and postmenopausal women in Asia: a systematic review

Abstract

Purpose

Method

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark

Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos)

Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the “ACROSS” study

Updated approach for the management of osteoporosis in Turkey: a consensus report

Research trends in osteoporosis in Asian countries and regions in the last 20 years